Medinger, M <br/><br/>
GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM.  [electronic resource] 

 -  Bone marrow transplantation  May 2013 
 - 715-21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2012.200  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bone Marrow--metabolism<br/>Female<br/>Graft vs Host Disease--etiology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunohistochemistry<br/>Leukemia, Myeloid, Acute--metabolism<br/>Male<br/>Middle Aged<br/>Neovascularization, Pathologic--metabolism<br/>Receptors, Vascular Endothelial Growth Factor--biosynthesis<br/>Vascular Endothelial Growth Factor A--biosynthesis<br/>Young Adult